3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Lymphoid
1
Classical hematology
1
Conditions
Venous Thromboembolism
1
Pulmonary Embolism
1
Multiple Myeloma
1
Lymphoma
1
Leukemia
1
Hematologic Neoplasms
1
Interventions
venetoclax
190
Cyclophosphamide
124
Azacitidine
112
Cytarabine
108
fludarabine
92
Specimen Handling
75
Biopsy
54
Daunorubicin
42
Methotrexate
40
Dexamethasone
37
Rituximab
34
blinatumomab
32
Vincristine
31
Decitabine
31
fludarabine phosphate
30
Injections
28
Granulocyte Colony-Stimulating Factor
28
Magnetic Resonance Spectroscopy
27
Whole-Body Irradiation
26
obinutuzumab
25
Idarubicin
25
acalabrutinib
23
Mycophenolic Acid
23
Prednisone
22
Melphalan
21
Busulfan
21
gilteritinib
19
Stem Cell Transplantation
19
Doxorubicin
19
ibrutinib
18
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
enoxaparin sodium
×
Other hematologic neoplasm
×
Clear all
NCT07270263
2025-12-26
HEM-DOAC
Medical University of Gdansk
Phase NA
Recruiting
100 enrolled